Nouveau Logo communiqué de presse.JPG
Theratechnologies fera une présentation à la conférence Cantor Fitzgerald Global Healthcare 2023
20 sept. 2023 07h00 HE | Theratechnologies
MONTRÉAL, 20 sept. 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur la mise au point...
Nouveau Logo communiqué de presse.JPG
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
20 sept. 2023 07h00 HE | Theratechnologies
MONTREAL, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
Longboard Logo.jpg
Longboard Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
29 sept. 2022 16h01 HE | Longboard Pharmaceuticals, Inc.
SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
Nouveau Logo communiqué de presse.JPG
Theratechnologies participe à la conférence mondiale sur les soins de santé Cantor Fitzgerald le 29 septembre 2021
16 sept. 2021 09h02 HE | Theratechnologies
MONTRÉAL, 16 sept. 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX : TH) (NASDAQ: THTX), une société biopharmaceutique axée sur le développement et la commercialisation...
Nouveau Logo communiqué de presse.JPG
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021
16 sept. 2021 09h02 HE | Theratechnologies
MONTREAL, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of...
logo_new.jpg
ObsEva SA to Participate in Cantor Global Healthcare Conference October 2-4, 2019
27 sept. 2019 01h00 HE | ObsEva SA
Geneva, Switzerland and Boston, MA – September 27, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...